Congress orders first systematic study of healthcare market consolidation
H.R. 10177 — Competition in State Healthcare Markets Act · Filed by Victoria Spartz (R-IN) · Introduced Aug 27, 2026 · Referred to committee
Your members of Congress
Enter a ZIP to see where your representative and both senators stood on this bill.
Looked up on this device — your ZIP is never stored on our servers.
What it does
This bill directs the HHS Assistant Secretary for Planning and Evaluation to conduct an annual study for 10 years on healthcare competition and consolidation at the state level, collecting data on licensing requirements, hospital and insurance mergers, state approval mechanisms for mergers, alternative insurance options, the number of healthcare providers, and market concentration indices. The findings must be published annually in reports to Congress and made publicly available in interactive datasets.
Why we flagged it
The bill's sole operative mechanism is a data-collection and reporting requirement. It does not regulate healthcare markets, restrict mergers, or impose new compliance burdens—it mandates systematic study and public disclosure of existing market conditions to inform future policy.
What the text implies
- Data on state licensing requirements and their variation may inform future federal preemption or harmonization efforts, potentially reducing state regulatory autonomy.
- Public disclosure of Herfindahl-Hirschman Index (HHI) scores and merger activity may increase scrutiny of healthcare consolidation and embolden antitrust enforcement or state-level regulatory action.
The full analysis lists 4 implications of this text.
Who it affects
The bill creates transparency and accountability by requiring systematic, public data collection on healthcare market consolidation and competition—information citizens and policymakers currently lack. This enables informed debate about healthcare market structure and may support future policy decisions to address anticompetitive consolidation.